SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is gaining traction due to key developments in AI integration, including joining the NVIDIA Inception Program, and expanding its cross-chain "Intents" technology for seamless interoperability across major blockchains. The community is enthusiastically highlighting NEAR's rapid user growth, improved tokenomics, and perceived undervaluation, fueling discussions about its potential for a significant rally.

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Inc

Coeptis Therapeutics is trending after securing shareholder approval for its transformative merger with Z Squared Inc., a major Dogecoin and Litecoin mining operation. The community is buzzing with anticipation for the official deal close, speculating on a significant revaluation and potential short squeeze as the company pivots from biotech to a dual-sector crypto-mining focus.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is trending as the community discusses its potential for a significant "rise" from current low valuations, driven by its unique "move-to-earn" utility that rewards physical activity. Many express optimism for its long-term future, with some noting recent upward momentum and technical indicators suggesting a potential buy.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending significantly due to its transformative all-stock acquisition of Valaris, creating an offshore drilling powerhouse with an expanded fleet and substantial backlog amidst a strong energy sector upcycle. The community is shrugging off initial mixed earnings, focusing on the combined entity's increased pricing power and potential for accelerated debt reduction.

Berachain

Berachain (BERA) is experiencing significant price volatility, driven by ongoing ecosystem upgrades, including new Proof-of-Liquidity vaults and governance enhancements. The community is sharply divided between those anticipating a major rally from its innovative technology and others expressing caution over past token unlocks and concerns about early holder activity.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amid discussions around recent workforce reductions and executive departures, signaling the company's efforts to streamline operations as it navigates persistent cash burn. The community remains sharply divided, with some anticipating a potential short squeeze and positive catalysts from its mid-size EV plans and Uber partnership, while others foresee further declines given ongoing concerns about vehicle demand and the broader competitive EV landscape.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is experiencing a surge in community interest and trading volume following multiple new exchange listings and significant advancements in its AI agent utility and token launch infrastructure. The strong bullish sentiment within the community highlights its perceived fundamental value and revenue-generating capabilities within the Base ecosystem and the burgeoning AI crypto sector.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene (CNC) is gaining significant attention following the House's approval of a three-year extension for Obamacare subsidies, a major positive catalyst for the healthcare insurer's market presence. This development is generating community optimism, especially after recent mixed earnings results and ongoing discussions regarding federal healthcare funding.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors rapidly position for a potential Nasdaq downturn, driven by intensifying geopolitical concerns and widespread belief that tech valuations are unsustainable, with many in the community anticipating significant upside for the inverse ETF.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

LUNC is trending as the community processes Do Kwon's prison sentencing, which many view as a fresh start, alongside discussions around Kraken's decision to maintain listings, ongoing Binance burns, and new ecosystem projects. Community members are optimistic about LUNC's surprising resilience during market dips and actively debate its path to recovery through continued supply reduction and new utility on the Terra Classic chain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Strong Sell Stocks for February 9th

GPRE, CRLBF and BSET have been added to the Zacks Rank #5 (Strong Sell) List on February 9, 2026.

Should You Buy GTBIF Stock After Marijuana Reclassification Order?

Shares of Green Thumb GTBIF jump nearly 35% on a marijuana rescheduling order, but pricing pressure and weak comps cloud the stock's near-term outlook.

Tilray Brands Strengthens Domestic Lead With Strong Q1 Cannabis Growth

TLRY posts a strong quarter as Canadian cannabis revenues grow and market shares climb across key product categories.

TLRY vs. CRLBF: Which Cannabis Player Offers Greater Upside?

Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth.

Cresco Labs Expands Operations Beyond U.S.: How to Play the Stock?

CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.

Cresco Labs Inc. (CRLBF) Reports Q3 Loss, Beats Revenue Estimates

Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -66.67% and +0.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for Oct. 17th

GYRE, DAR and CRLBF have been added to the Zacks Rank #5 (Strong Sell) List on October 17, 2025.

Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?

CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.

Cresco Labs Inc. (CRLBF) Reports Q2 Loss, Lags Revenue Estimates

Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -25.00% and -0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Perrigo (PRGO) Lags Q2 Earnings and Revenue Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of -3.39% and -2.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.

Current Price	$0.96
Prev Close	$1.11
Open	$1.19
Dividend Yield	0.00%
50-Day Moving Average	$1.17
Beta	1.03
Avg. Volume	549,904.95
PE Ratio	-6.50

52-Week High	$2.30
52-Week Low	$0.4256
Market Capitalization	$343.32M
EPS (Annual)	-$0.2155
Price to Book	0.80
Revenue Per Employee	$249,773.45

CRLBF
Cresco Labs Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRLBF News

CRLBFCresco Labs Inc